Johnson & Johnson Innovative Medicine Unclassified
FDA Approved Drugs

Johnson & Johnson Innovative Medicine Unclassified

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Unclassified
  • Total Records 6
  • Latest Approval Date -
  • Data Source FDA
  • First Approval Date -
All
154
View
Unclassified
6
View
Discontinued
83
View
RX
65
View
Company Overview

Company

Johnson & Johnson Innovative Medicine Unclassified

Country

U.S.A

Website

Visit Website

Email

Social Profiles

Company Snapshot

Johnson & Johnson Innovative Medicine Unclassified

1125 Trenton-Harbourton Road, P.O. Box 200, Titusville, NJ 08560

U.S.A

www.janssen.com/us/ View on Map
FDA Approved Drug Records ( 6 records )
-
Unclassified Application: 220092

Drug Name

PREZCOBIX

Product Number

2

Dosage Form

-

Strength

675MG/150MG

Approval Date

-

220092 / 2

Active Ingredient

DARUNAVIR AND COBICISTAT

Application Number

220092

Product Number

2

Dosage Form

-

Strength

675MG/150MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 220092

Drug Name

PREZCOBIX

Product Number

3

Dosage Form

-

Strength

600MG/90MG

Approval Date

-

220092 / 3

Active Ingredient

DARUNAVIR AND COBICISTAT

Application Number

220092

Product Number

3

Dosage Form

-

Strength

600MG/90MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 202439

Drug Name

XARELTO

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

-

202439 / 1

Active Ingredient

RIVAROXABAN

Application Number

202439

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 202439

Drug Name

XARELTO

Product Number

2

Dosage Form

-

Strength

15MG

Approval Date

-

202439 / 2

Active Ingredient

RIVAROXABAN

Application Number

202439

Product Number

2

Dosage Form

-

Strength

15MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 202439

Drug Name

XARELTO

Product Number

3

Dosage Form

-

Strength

20MG

Approval Date

-

202439 / 3

Active Ingredient

RIVAROXABAN

Application Number

202439

Product Number

3

Dosage Form

-

Strength

20MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 202439

Drug Name

XARELTO

Product Number

4

Dosage Form

-

Strength

2.5MG

Approval Date

-

202439 / 4

Active Ingredient

RIVAROXABAN

Application Number

202439

Product Number

4

Dosage Form

-

Strength

2.5MG

Approval Date

-

Regulatory Status

Unclassified

Related Databases
  • FDA Inspections
    7 View
  • EDQM CEP
    46 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    18 View
  • FDA Approved Drugs Database
    154 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
6 total
  • Unclassified
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

PREZCOBIX

Application Number

220092

Product Number

2

Active Ingredient

DARUNAVIR AND COBICISTAT

Dosage Form

-

Strength

675MG/150MG

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit